576 results on '"Passman, Rod S"'
Search Results
2. Use of continuous cardiac monitoring to assess the influence of atrial fibrillation burden and patterns on patient symptoms and healthcare utilization: The DEFINE AFib study
Catalog
Books, media, physical & digital resources
3. Concomitant ablation of atrial fibrillation: New pacemakers and early rhythm recovery
4. Associations Between Changes in Maximum Daily Atrial Fibrillation Duration, Ischemic Stroke, and Mortality
5. Validation of the SCALE-CryoAF risk model to predict very late return of atrial fibrillation after cryoballoon ablation
6. Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices
7. Usformer: A small network for left atrium segmentation of 3D LGE MRI
8. Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization
9. Can we predict success when failure is obscured?
10. Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry
11. Abstract 18852: Machine Learning to Predict Atrial Fibrillation Recurrence Using Pulmonary Vein Morphology
12. Abstract 17865: Machine Learning With Multimodal Pre Ablation Imaging for Predicting Recurrence in Atrial Fibrillation Patients
13. Abstract 17206: Targeted Ablation at Regions of High Oxidative Injury in Persistent Atrial Fibrillation in a Canine Model — A New Electrogram Based Therapeutic Strategy in Atrial Fibrillation?
14. Abstract 15388: Atrial Fibrillation Burden Reduction From Antiarrhythmic Drugs in Patients With Cardiac Implantable Electronic Devices
15. Abstract 14772: Subcutaneous Implantable Cardioverter Defibrillator Extractions: A Single-Healthcare System Analysis of Incidence and Indications
16. Abstract 13924: Combined Gene Therapy Approach Targets Parasympathetic Signaling and Oxidative Stress to Reverse Pre-Existing Persistent Atrial Fibrillation in a Canine Model
17. Abstract 13928: Targeted Atrial Inhibition of Galphaq Signaling With Inhibitory Peptides Attenuates Fibrosis and Inducibility of Atrial Fibrillation in a Canine Heart Failure Model
18. Abstract 13123: Sex-Based Disparity in Referral for Catheter Ablation for Atrial Fibrillation at a Single Integrated Health System
19. Evaluation of a clinical score for predicting atrial fibrillation in cryptogenic stroke patients with insertable cardiac monitors: results from the CRYSTAL AF study
20. Impact of atrial fibrillation ablation on activity minutes in patients with cardiac implantable electronic devices
21. Mobile Health for Arrhythmia Diagnosis and Management
22. Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation
23. Use of Smartphones and Wearables for Arrhythmia Monitoring
24. HRS White Paper on Clinical Utilization of Digital Health Technology
25. Abstract 15072: Targeted Atrial Inhibition of Parasympathetic Signaling With GiGo Inhibitory Peptides Attenuates Electrical Remodeling and Development of Persistent Atrial Fibrillation in a Canine Model
26. Abstract 14782: Expression of Ngf Shrna in the Left Atrial Appendage Alone is Sufficient to Attenuate Global Left Atrial Parasympathetic and Sympathetic Nerve Sprouting and Resulting Development of Persistent Atrial Fibrillation in a Canine Model
27. Abstract 14784: Outcomes Associated With Implementation of an Intravenous Sotalol Initiation Protocol
28. Improvement in renal function following cryoballoon ablation for atrial fibrillation
29. Association between high‐density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization.
30. Correction: Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry
31. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients
32. MRI Investigation of the Association of Left Atrial and Left Atrial Appendage Hemodynamics with Silent Brain Infarction
33. A novel risk model for very late return of atrial fibrillation beyond 1 year after cryoballoon ablation: the SCALE-CryoAF score
34. Characterization of atrial flutter after pulmonary vein isolation by cryoballoon ablation
35. Transparent sharing of digital health data: A call to action
36. Discriminative Ability of CHA2DS2-VASc and HAS-BLED Score in Whites and Nonwhites
37. Real-World Incidence of Pacemaker and Defibrillator Implantation Following Diagnostic Monitoring With an Insertable Cardiac Monitor
38. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study
39. Outcomes With Novel Oral Anticoagulants in Obese Patients who Underwent Electrical Cardioversion for Atrial Tachyarrhythmias
40. When is Device-Detected Atrial Fibrillation Actionable?
41. Development and validation of a dual sensing scheme to improve accuracy of bradycardia and pause detection in an insertable cardiac monitor
42. Bronchial effects of cryoballoon ablation for atrial fibrillation
43. Abstract 17251: Knockdown of NOX2 Reduces Rotational Drivers in AF - A New Gene Therapy Approach for Atrial Fibrillation?
44. Abstract 17050: Pulmonary Vein Isolation Leads to Decreased Stability of Rotational Activities in Atrial Regions Remote From the Site of Ablation - A New Mechanism by Which Pulmonary Vein Isolation Leads to Beneficial Remodeling in the Atria
45. Abstract 15240: Evaluation of the Performance and Safety of Wideband Cardiac MRI in Patients With a Cardiac Implantable Electronic Device (CIED)
46. Abstract 13752: Impact of Pre-ablation Weight Changes on Freedom From Atrial Fibrillation
47. Abstract 13456: Association of Chronic Inflammatory Diseases With Incident Atrial Fibrillation
48. Abstract 12993: Oral Anticoagulation Prescription Depends on Both Atrial Fibrillation Duration and CHA2DS2-VASc Score
49. Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology
50. Response by Kaplan et al to Letter Regarding Article, “Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score”
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.